Search

Search Results
Results 391 - 400 of 619 for cancer
  • DBL Papaverine Hydrochloride
    Drug - 23 Mar 2022
    Consumer Medicine Information (CMI) about DBL Papaverine Hydrochloride intended for persons living in Australia.
  • Aldara
    Drug - 2 Dec 2021
    Consumer Medicine Information (CMI) about Aldara intended for persons living in Australia.
  • Noxafil concentrated injection
    Drug - 25 Nov 2021
    Consumer Medicine Information (CMI) about Noxafil concentrated injection intended for persons living in Australia.
  • Noxafil
    Drug - 25 Nov 2021
    Consumer Medicine Information (CMI) about Noxafil intended for persons living in Australia.
  • Deferasirox-Teva
    Drug - 13 Oct 2021
    Consumer Medicine Information (CMI) about Deferasirox-Teva intended for persons living in Australia.
  • Actiq
    Drug - 12 Aug 2021
    Consumer Medicine Information (CMI) about Actiq (fentanyl citrate) intended for persons living in Australia.
  • Valcyte Powder for Oral Solution
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Valcyte Powder for Oral Solution (valganciclovir) intended for persons living in Australia.
  • Thioprine 50
    Drug - 12 Feb 2020
    Consumer Medicine Information (CMI) about Thioprine 50 (azathioprine film-coated tablets) intended for persons living in Australia.
  • DBL Fentanyl Injection
    Drug - 23 Oct 2025
    Consumer Medicine Information (CMI) about DBL Fentanyl Injection intended for persons living in Australia.
  • Inpler
    Drug - 23 Oct 2025
    Consumer Medicine Information (CMI) about Inpler intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback